Order Article Reprints

Gaule P, Mukherjee N, Corkery B, Eustace AJ, Gately K, Roche S, O’Connor R, O’Byrne KJ, Walsh N, Duffy MJ, et al. Dasatinib Treatment Increases Sensitivity to c-Met Inhibition in Triple-Negative Breast Cancer Cells. Cancers. 2019; 11(4):548. https://doi.org/10.3390/cancers11040548

Gaule, Patricia, Nupur Mukherjee, Brendan Corkery, Alex J. Eustace, Kathy Gately, Sandra Roche, Robert O’Connor, Kenneth J. O’Byrne, Naomi Walsh, Michael J. Duffy, and et al. 2019. "Dasatinib Treatment Increases Sensitivity to c-Met Inhibition in Triple-Negative Breast Cancer Cells" Cancers 11, no. 4: 548. https://doi.org/10.3390/cancers11040548

Gaule, P., Mukherjee, N., Corkery, B., Eustace, A. J., Gately, K., Roche, S., O’Connor, R., O’Byrne, K. J., Walsh, N., Duffy, M. J., Crown, J., & O’Donovan, N. (2019). Dasatinib Treatment Increases Sensitivity to c-Met Inhibition in Triple-Negative Breast Cancer Cells. Cancers, 11(4), 548. https://doi.org/10.3390/cancers11040548